Evaluation of a prototype electronic personal health record for patients with idiopathic thrombocytopenic purpura

Patient Preference and Adherence

Volumn 6, Issue , 2012, Pages 725-734

  Chiche, Laurent ^a   Brescianini, Alessandra ^a   Mancini, Julien ^b   Servy, Hervé ^c   Durand, Jean Marc ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

^b TIMONE HOSPITAL   (France)

^c Association AIMSU   (France)

Author keywords

Electronic personal health records; Idiopathic thrombocytopenic purpura; Rare diseases

Indexed keywords

ACCESS TO INFORMATION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER INTERFACE; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH CARE PERSONNEL; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; PATIENT COMPLIANCE; PATIENT INFORMATION; PILOT STUDY; POSTAL MAIL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE;

EID: 84885975571     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S36320     Document Type: Article

References (7)

1. Orphanet: the portal for rare diseases and orphan drugs. Available from: http://www.orpha.net. Accessed September 10, 2010.
2. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3-40.
3. Mathias SD, Bussel JB, George JN, McMillan R, Okano GJ, Nichol JL. A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation. Health Qual Life Outcomes. 2007;5:11.
4. Sanoia. La fiche Santé anonyme. Available from: http://www.sanoia.com/fiche-sante/. Accessed May 3, 2012.
5. Trijau S, Servy H, Selamnia A, Pradel V, Lafforgue P, Pham T. Personal health records in rheumatoid arthritis: quality and adhesion factors. Arthritis Rheum. 2011;63:S10.
6. Anhøj J, Moldrup C. Feasibility of collecting diary data from asthma patients through mobile phones and SMS (short message service): response rate analysis and focus group evaluation from a pilot study. J Med Internet Res. 2004;6:e42.
7. George JN, Mathias SD, Go RS, et al. Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. Br J Haematol. 2009;144:409-415.